10 July 2015
Horse Health Week Launches 21st September
Vets Urged to Ride the Wave on Equine Preventive Healthcare
Milton Keynes, 10th July, 2015 – The Keeping Britain’s Horses Healthy campaign has actively raised awareness of the issues surrounding equine preventive healthcare over the last year and, as part of this programme, MSD Animal Health is now launching the first Horse Health Week (HHW), starting on 21st September 2015. This promotional week will support vets’ communications with their clients through educational materials for owners, news and features in the horse media, social media graphics and email templates and will be supported by the launch of a new KBHH website (www.healthyhorses.co.uk)
MSD Animal Health will be providing vets with a HHW toolkit on a USB stick that will contain a range of materials to support them during the week. The content will include videos and a selection of social media graphics promoting HHW, the website, and the seven ‘Responsible Horse Owner’ booklets which vets can share through their various social media channels.
Peter Young, Equine Business Manager adds: “Horse Health Week is a natural development within our successful Keeping Britain’s Horses Healthy campaign. We have been delighted with the large number of practices that have become involved in the programme and extended the dialogue on equine preventive healthcare throughout the year. We are now supporting vets with a highly focused campaign on the seven key health topics which are most important to the horse. We urge equine vets to make the most of this opportunity, to download the materials and communicate on preventive healthcare issues with their clients and make the most of the resources available to them.”
For full details talk to your MSD Animal Health Account Manager, call us on 01908 685685 or refer to www.healthyhorses.co.uk.
About MSD Animal Health
Today's MSD is a global healthcare leader working to help the world be well. MSD Animal Health, a division of Merck & Co., Inc., Kenilworth, NJ, USA., is the global animal health business unit of MSD. Through its commitment to theScience of Healthier Animals™, MSD Animal Health offers veterinarians, farmers, pet owners and governments one of the widest range of veterinary pharmaceuticals, vaccines and health management solutions and services. MSD Animal Health is dedicated to preserving and improving the health, well-being and performance of animals. It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. MSD Animal Health is present in more than 50 countries, while its products are available in some 150 markets. For more information, visit www.msd-animal-health.com or connect with us on LinkedIn.
MSD forward-Looking Statement
This presentation includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. These statements are based upon the current beliefs and expectations of MSD’s management and are subject to significant risks and uncertainties. There can be no guarantees with respect to pipeline products that the products will receive the necessary regulatory approvals or that they will prove to be commercially successful. If underlying assumptions prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking statements.
Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; MSD’s ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of MSD’s patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and/or regulatory actions.
MSD undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. Additional factors that could cause results to differ materially from those described in the forward-looking statements can be found in MSD’s 2014 Annual Report on Form 10-K and the company’s other filings with the Securities and Exchange Commission (SEC) available at the SEC’s Internet site (www.sec.gov).